What you should know about wearable glucose monitors in wake of recall

About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, ...

Abbott reports positive FreeDM2 study results for CGM

Abbott has announced results from the FreeDM2 randomised controlled trial (RCT), indicating that improved glucose outcomes ...

Diabetics who rely on glucose monitors are alarmed by recall linked to 7 deaths

A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.
CNET

Expert-Approved Continuous Glucose Monitors to Track Your Glucose Daily

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...
Drug Delivery Business

Abbott study highlights better glucose outcomes with Libre CGM in type 2 diabetes on basal insulin

Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).